Previous 10 | Next 10 |
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on ...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences: T...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Thursday, February 29, 2...
2024-01-26 16:59:28 ET Gainers: Olema Pharmaceuticals ( OLMA ) +3% . Baijiayun Group ( RTC ) +3% . Cipher Mining ( CIFR ) +2% . Evolus, ( EOLS ) +2% . SSR Mining ( SSRM ) +2% . Losers: Progress Software ...
2024-01-23 02:46:06 ET Summary GoodRx has a strong value proposition that drives continuous adoption, offering cost savings and price comparisons on medications. The company benefits from a strong network effect, with consumers, PBMs, and pharmacies incentivized to join the networ...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien term loan facility ...
New report reveals that by improving medication access and adherence, GoodRx has helped save Americans $65 billion and the healthcare system over $5 billion GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company’s imp...
2024-01-11 08:30:00 ET Summary GoodRx Holdings announced preliminary financial results for Q4 2023, exceeding guidance on the top line. The company's financial performance in previous quarters has been disappointing, with declining revenue and profitability metrics. Management...
2024-01-10 09:34:22 ET Goodrx ( NASDAQ: GDRX ) shares gained as much as 9% premarket on Wednesday after the healthcare savings platform issued higher-than-expected sales for the fourth quarter of 2023. The company reported preliminary Q4 revenue in the range of $195M to $197...
News, Short Squeeze, Breakout and More Instantly...
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® PR Newswire First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and S...
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management ...
Former Genentech CEO brings over 35 years of pharmaceutical and healthcare expertise to GoodRx GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the ...